G

Genelux Corp
NASDAQ:GNLX

Watchlist Manager
Genelux Corp
NASDAQ:GNLX
Watchlist
Price: 3.46 USD -0.57% Market Closed
Market Cap: 130.5m USD

Relative Value

There is not enough data to reliably calculate the relative value of GNLX.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

GNLX Relative Value
Base Case
Not Available
G
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
0
Median 3Y
1 547.6
Median 5Y
1 547.6
Industry
7.3
vs History
vs Industry
Median 3Y
-4.8
Median 5Y
-4.8
Industry
23.3
Forward
-3.6
vs History
vs Industry
Median 3Y
-6.6
Median 5Y
-6.6
Industry
19.8
vs History
vs Industry
Median 3Y
-6.4
Median 5Y
-6.4
Industry
22.6
vs History
53
vs Industry
28
Median 3Y
5
Median 5Y
5
Industry
2.7
vs History
vs Industry
0
Median 3Y
1 417.2
Median 5Y
1 417.2
Industry
7.6
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
9.4
vs History
vs Industry
Median 3Y
-3.5
Median 5Y
-3.5
Industry
4.7
Forward
-4.2
vs History
vs Industry
Median 3Y
-3.4
Median 5Y
-3.4
Industry
4.8
Forward
-2.7
vs History
vs Industry
Median 3Y
-5.1
Median 5Y
-5.1
Industry
5.3
vs History
vs Industry
Median 3Y
-5
Median 5Y
-5
Industry
3.8
vs History
vs Industry
5
Median 3Y
-23.6
Median 5Y
-23.6
Industry
5

Multiples Across Competitors

GNLX Competitors Multiples
Genelux Corp Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Genelux Corp
NASDAQ:GNLX
127.9m USD 0 -5.6 -3.9 -3.9
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 841 650.5 -160 844.3 -195 316.3 -193 087.6
US
Abbvie Inc
NYSE:ABBV
346.7B USD 6 83.3 15.8 23.3
US
Amgen Inc
NASDAQ:AMGN
161.1B USD 4.7 27.2 14.5 24
US
Gilead Sciences Inc
NASDAQ:GILD
141.8B USD 4.9 23.8 10.3 14.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
123.4B USD 11.1 -124.8 26.6 27.9
US
Epizyme Inc
F:EPE
94.1B EUR 2 081.7 -531.2 -578.4 -563
AU
CSL Ltd
ASX:CSL
117.4B AUD 5 27.9 17.2 21.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
60.7B USD 4.3 13.5 12.1 13.5
US
Seagen Inc
F:SGT
39.3B EUR 20.1 -61.5 -66.3 -59.8
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
42.1B USD 17.9 -156 -700 -350.8
P/S Multiple
Revenue Growth P/S to Growth
US
G
Genelux Corp
NASDAQ:GNLX
Average P/S: 3 384 380.6
Not Available
1 590%
N/A
FR
Pharnext SCA
OTC:PNEXF
33 841 650.5
N/A N/A
US
Abbvie Inc
NYSE:ABBV
6
8%
0.8
US
Amgen Inc
NASDAQ:AMGN
4.7
4%
1.2
US
Gilead Sciences Inc
NASDAQ:GILD
4.9
3%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
11.1
10%
1.1
US
E
Epizyme Inc
F:EPE
2 081.7
N/A N/A
AU
CSL Ltd
ASX:CSL
5
7%
0.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
4.3
4%
1.1
US
S
Seagen Inc
F:SGT
20.1
30%
0.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
17.9
29%
0.6
P/E Multiple
Earnings Growth PEG
US
G
Genelux Corp
NASDAQ:GNLX
Average P/E: 35.1
Negative Multiple: -5.6
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 844.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
83.3
88%
0.9
US
Amgen Inc
NASDAQ:AMGN
27.2
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
23.8
188%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -124.8 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -531.2 N/A N/A
AU
CSL Ltd
ASX:CSL
27.9
16%
1.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.5
7%
1.9
US
S
Seagen Inc
F:SGT
Negative Multiple: -61.5 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -156 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
G
Genelux Corp
NASDAQ:GNLX
Average EV/EBITDA: 16.1
Negative Multiple: -3.9
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 316.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.8
13%
1.2
US
Amgen Inc
NASDAQ:AMGN
14.5
17%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
10.3
6%
1.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.6
17%
1.6
US
E
Epizyme Inc
F:EPE
Negative Multiple: -578.4 N/A N/A
AU
CSL Ltd
ASX:CSL
17.2
11%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.1
11%
1.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -66.3 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -700 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
G
Genelux Corp
NASDAQ:GNLX
Average EV/EBIT: 20.8
Negative Multiple: -3.9
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -193 087.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.3
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
24
32%
0.7
US
Gilead Sciences Inc
NASDAQ:GILD
14.2
11%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
27.9
17%
1.6
US
E
Epizyme Inc
F:EPE
Negative Multiple: -563 N/A N/A
AU
CSL Ltd
ASX:CSL
21.5
14%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.5
11%
1.2
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.8 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -350.8 N/A N/A